A controversial issue - drug companies serve patients by developing pain killers. Unfortunately these have so far been opioid based, therefore addictive in spite of marketing semantics. One might be forgiven for thinking that our medical professionals and government regulatory agencies would have paid attention to the addiction factor instead of helping with the whitewash. An opiod is an opioid is an opioid - controlled release is a secondary convenience.